Antitumor agent-115

Antitumor agent-115 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:Antitumor agent-115
CAS:2759277-20-6
Package:25mg;1520USD|100mg;2500USD|50mg;1980USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:Antitumor agent-115
CAS:2759277-20-6
Package:25mg/RMB 10600;100mg/RMB 17500;50mg/RMB 13800

Antitumor agent-115 manufacturers

  • Antitumor agent-115
  • Antitumor agent-115 pictures
  • $1520.00 / 25mg
  • 2025-08-21
  • CAS:2759277-20-6
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
Antitumor agent-115 Basic information
Product Name:Antitumor agent-115
Synonyms:Antitumor agent-115;Pyrrolidinium, 2-[(dodecyloxy)carbonyl]-1,1-dimethyl-, chloride (1:1)
CAS:2759277-20-6
MF:C19H38NO2.Cl
MW:347.96
EINECS:
Product Categories:
Mol File:2759277-20-6.mol
Antitumor agent-115 Structure
Antitumor agent-115 Chemical Properties
Safety Information
MSDS Information
Antitumor agent-115 Usage And Synthesis
UsesAntitumor agent-115 (SS-12) is an effective anti-tumor compound with an IC50 value of 0.34 μM-24.14 μM for cell line 4T1. Antitumor agent-115 can block the cell cycle of mouse breast cancer cell line 4T1, reduce the mitochondrial membrane potential, and induce apoptosis, and the IC50 value is 8-25 μmol/L for cell viability. Antitumor agent-115 can be used for breast cancer research[1].
in vivo

Antitumor agent-115 (SS-12) (10 mg stachydrine/kg equivale, 200 μL for Oral administration) has greater bioavailability in rats[1].
Antitumor agent-115 (0.2 mmol/kg for Oral administration) has anti-tumor effects in breast cancer model mice and improves morphological structure of spleen in model mice[1].

Animal Model:Rats[1]
Dosage:10 mg stachydrine/kg equivale, 200 μL
Administration:Oral administration (p. o.)
Result:Exhibited high systemic exposure with 6.10 μg/mL of Cmax value and 14.75 h μg/mL of AUC0-t value.
Animal Model:Tumor-bearing mice[1]
Dosage:0.2 mmol/kg
Administration:Oral administration (p. o.)
Result:Inhibitory rate was 51.47% ( P < 0.01)
Displayed significant tumor cell shrinkage and larger void areas in tumor tissues
Exhibited more weight loss than the model group and other treatment groups, increased of both AST and ALT levels and reduced spleen index of the tumor-bearing mice
References[1] Zeng H, et al. Synthesis, characterization and anti-breast cancer activities of stachydrine derivatives. Eur J Med Chem. 2023 Jul 26;259:115679. DOI:10.1016/j.ejmech.2023.115679
Antitumor agent-115 Preparation Products And Raw materials
Tag:Antitumor agent-115(2759277-20-6) Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.